Adam Dubow
CIK 1744507 · Gen Counsel & Secretary · last filed 2026-04-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$956.3K
Companies
2
Total Filings
30
Lifetime Open-Market Net
-$1.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Gen Counsel & Secretary | 0 | $21.53 | $0 | -$476.8K | 15 | 2026-04-23 |
| BMY | SVP,ChiefCompliance&EthicsOff. | 14,749 | $64.84 | $956.3K | -$722.3K | 9 | 2021-08-03 |
Recent Filings · Page 2 of 3
30 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-21 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | +7,440 | -$55.6K | EDGAR |
| 2025-02-18 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Notice (144) | −4,646 | -$55.6K | EDGAR |
| 2025-01-31 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-11-19 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | +5,234 | -$41.8K | EDGAR |
| 2024-08-19 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | +5,197 | -$44.8K | EDGAR |
| 2024-05-17 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | +5,146 | -$52.3K | EDGAR |
| 2024-05-16 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Notice (144) | −3,253 | -$52.3K | EDGAR |
| 2024-02-20 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | +5,157 | -$49.4K | EDGAR |
| 2024-01-09 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-11-17 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | +8,287 | -$62.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.